{{Rsnum
|rsid = 16874954
|Gene = PLA2G7
|Orientation=plus
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Chromosome=6
|position=46709361
|Gene_s=PLA2G7
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Status=Merged
|Merged=76863441
}}{{omim
| id = 601690
| variant = 0001
| desc    = PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE DEFICIENCY
| rsnum   = 16874954
}}

{{ neighbor
| rsid = 1051931
| distance = 4155
}}

{{ population diversity
| geno1 = (A;A)
| geno2 = (A;C)
| geno3 = (C;C)
| CEU | 0.0 | 1.7 | 98.3
| CHB | 0.0 | 4.4 | 95.6
| JPT | 2.2 | 31.1 | 66.7
| YRI | 0.0 | 3.3 | 96.7
}}

{{PMID|21834908}} Association between lipoprotein-associated phospholipase A2 gene polymorphism and coronary artery disease in the Chinese Han population.

{{GET Evidence
|gene=PLA2G7
|aa_change=Val279Phe
|aa_change_short=V279F
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=recessive
|quality_scores=Array
|dbsnp_id=rs16874954
|overall_frequency_n=3
|overall_frequency_d=128
|overall_frequency=0.0234375
|n_genomes=2
|n_genomes_annotated=0
|n_haplomes=3
|n_articles=4
|n_articles_annotated=4
|qualityscore_in_silico=3
|qualitycomment_in_silico=Y
|qualityscore_in_vitro=1
|qualitycomment_in_vitro=Y
|qualityscore_case_control=5
|qualitycomment_case_control=Y
|qualityscore_familial=3
|qualitycomment_familial=Y
|qualityscore_severity=1
|qualitycomment_severity=Y
|qualityscore_treatability=0
|qualitycomment_treatability=Y
|in_omim=Y
|pph2_score=0.975
|nblosum100=3
|autoscore=4
|webscore=N
|summary_short=This variant causes PAF acetylhydrolase deficiency and affects 4% of Japanese. It is associated with heightened risk of stroke and asthma and lower risk for cardiovascular disease.
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}